Literature DB >> 17459415

Neurotrophic cross-talk between the nervous and immune systems: relevance for repair strategies in multiple sclerosis?

Reinhard Hohlfeld1.   

Abstract

Autoreactive T and B cells are regular components of the healthy immune system. It has been proposed that some of these cells might have a protective function. Recent studies support this notion by demonstrating that a) myelin-autoreactive T cells show neuroprotective effects in vivo, and b) activated antigen-specific human T cells and other immune cells produce bioactive brain-derived neurotrophic factor (BDNF) and other neurotrophic factors in vitro. Furthermore, neurotrophic factors are expressed in different types of inflammatory cells in brain lesions of patients with acute disseminated leukoencephalopathy or multiple sclerosis. It seems plausible that the immune cell-mediated import of neurotrophic factors into the central nervous system has functional consequences, with obvious implications for the therapy of multiple sclerosis and other neuroimmunological diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17459415     DOI: 10.1016/j.jns.2007.03.012

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  14 in total

Review 1.  Blood Biomarkers as Outcome Measures in Inflammatory Neurologic Diseases.

Authors:  Nabil K El Ayoubi; Samia J Khoury
Journal:  Neurotherapeutics       Date:  2017-01       Impact factor: 7.620

Review 2.  Inflammation in neurodegenerative diseases.

Authors:  Sandra Amor; Fabiola Puentes; David Baker; Paul van der Valk
Journal:  Immunology       Date:  2010-02       Impact factor: 7.397

3.  Neurotrophic Factors in Experimental Cerebral Acanthamoebiasis.

Authors:  Natalia Łanocha-Arendarczyk; Karolina Kot; Irena Baranowska-Bosiacka; Patrycja Kapczuk; Aleksandra Łanocha; Danuta Izabela Kosik-Bogacka
Journal:  Int J Mol Sci       Date:  2022-04-29       Impact factor: 6.208

Review 4.  Myelin repair strategies: a cellular view.

Authors:  Vittorio Gallo; Regina C Armstrong
Journal:  Curr Opin Neurol       Date:  2008-06       Impact factor: 5.710

Review 5.  A review of genome-wide association studies for multiple sclerosis: classical and hypothesis-driven approaches.

Authors:  V V Bashinskaya; O G Kulakova; A N Boyko; A V Favorov; O O Favorova
Journal:  Hum Genet       Date:  2015-09-25       Impact factor: 4.132

6.  Complexity of trophic factor signaling in experimental autoimmune encephalomyelitis: differential expression of neurotrophic and gliotrophic factors.

Authors:  Fei Song; Manoj Bandara; Harvinder Deol; Jeffrey A Loeb; Joyce Benjamins; Robert P Lisak
Journal:  J Neuroimmunol       Date:  2013-06-12       Impact factor: 3.478

Review 7.  The usefulness of immunotherapy in pediatric neurodegenerative disorders: A systematic review of literature data.

Authors:  Giovanna Vitaliti; Omidreza Tabatabaie; Nassim Matin; Caterina Ledda; Piero Pavone; Riccardo Lubrano; Agostino Serra; Paola Di Mauro; Salvatore Cocuzza; Raffaele Falsaperla
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

8.  Immune modulation and increased neurotrophic factor production in multiple sclerosis patients treated with testosterone.

Authors:  Stefan M Gold; Sara Chalifoux; Barbara S Giesser; Rhonda R Voskuhl
Journal:  J Neuroinflammation       Date:  2008-07-31       Impact factor: 8.322

9.  VGF expression by T lymphocytes in patients with Alzheimer's disease.

Authors:  Stefan Busse; Johann Steiner; Sarah Glorius; Henrik Dobrowolny; Sabrina Greiner-Bohl; Christian Mawrin; Ursula Bommhardt; Roland Hartig; Bernhard Bogerts; Mandy Busse
Journal:  Oncotarget       Date:  2015-06-20

Review 10.  The role of neurotrophins in multiple sclerosis-pathological and clinical implications.

Authors:  Alicja Kalinowska-Lyszczarz; Jacek Losy
Journal:  Int J Mol Sci       Date:  2012-10-22       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.